Chemicals - Specialty
Compare Stocks
5 / 10Stock Comparison
CBT vs KRO vs TROX vs IOSP vs RPM
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Chemicals
Chemicals - Specialty
Chemicals - Specialty
CBT vs KRO vs TROX vs IOSP vs RPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty | Chemicals | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $4.24B | $811M | $1.34B | $1.91B | $12.99B |
| Revenue (TTM) | $3.58B | $1.88B | $2.92B | $1.78B | $7.58B |
| Net Income (TTM) | $285M | $-134M | $-359M | $117M | $667M |
| Gross Margin | 24.8% | 10.1% | 5.8% | 27.7% | 41.2% |
| Operating Margin | 15.7% | -3.1% | -4.8% | 8.7% | 12.0% |
| Forward P/E | 13.0x | — | — | 15.5x | 18.5x |
| Total Debt | $1.22B | $577M | $3.59B | $90M | $2.96B |
| Cash & Equiv. | $258M | $37M | $211M | $293M | $302M |
CBT vs KRO vs TROX vs IOSP vs RPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Cabot Corporation (CBT) | 100 | 227.5 | +127.5% |
| Kronos Worldwide, I… (KRO) | 100 | 72.2 | -27.8% |
| Tronox Holdings plc (TROX) | 100 | 126.7 | +26.7% |
| Innospec Inc. (IOSP) | 100 | 99.4 | -0.6% |
| RPM International I… (RPM) | 100 | 135.6 | +35.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CBT vs KRO vs TROX vs IOSP vs RPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CBT ranks third and is worth considering specifically for value.
- Lower P/E (13.0x vs 18.5x)
Among these 5 stocks, KRO doesn't own a clear edge in any measured category.
TROX is the #2 pick in this set and the best alternative if dividends and momentum is your priority.
- 3.6% yield, vs RPM's 2.0%
- +76.9% vs IOSP's -14.9%
IOSP is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 12 yrs, beta 0.70, yield 2.2%
- Lower volatility, beta 0.70, Low D/E 6.7%, current ratio 2.79x
- PEG 0.48 vs RPM's 1.03
- Beta 0.70, yield 2.2%, current ratio 2.79x
RPM carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 0.5%, EPS growth 17.3%, 3Y rev CAGR 3.2%
- 134.7% 10Y total return vs CBT's 115.7%
- 0.5% revenue growth vs CBT's -7.0%
- 8.8% margin vs TROX's -12.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 0.5% revenue growth vs CBT's -7.0% | |
| Value | Lower P/E (13.0x vs 18.5x) | |
| Quality / Margins | 8.8% margin vs TROX's -12.3% | |
| Stability / Safety | Beta 0.70 vs TROX's 2.37, lower leverage | |
| Dividends | 3.6% yield, vs RPM's 2.0% | |
| Momentum (1Y) | +76.9% vs IOSP's -14.9% | |
| Efficiency (ROA) | 8.5% ROA vs KRO's -9.4%, ROIC 13.3% vs -1.9% |
CBT vs KRO vs TROX vs IOSP vs RPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CBT vs KRO vs TROX vs IOSP vs RPM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CBT leads in 1 of 6 categories
RPM leads 1 • KRO leads 0 • TROX leads 0 • IOSP leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — CBT and RPM each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
RPM is the larger business by revenue, generating $7.6B annually — 4.3x IOSP's $1.8B. RPM is the more profitable business, keeping 8.8% of every revenue dollar as net income compared to TROX's -12.3%. On growth, KRO holds the edge at +4.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $3.6B | $1.9B | $2.9B | $1.8B | $7.6B |
| EBITDAEarnings before interest/tax | $731M | -$9M | $166M | $198M | $1.1B |
| Net IncomeAfter-tax profit | $285M | -$134M | -$359M | $117M | $667M |
| Free Cash FlowCash after capex | $459M | $35M | -$139M | $88M | $583M |
| Gross MarginGross profit ÷ Revenue | +24.8% | +10.1% | +5.8% | +27.7% | +41.2% |
| Operating MarginEBIT ÷ Revenue | +15.7% | -3.1% | -4.8% | +8.7% | +12.0% |
| Net MarginNet income ÷ Revenue | +8.0% | -7.1% | -12.3% | +6.6% | +8.8% |
| FCF MarginFCF ÷ Revenue | +12.8% | +1.9% | -4.8% | +4.9% | +7.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.4% | +4.1% | +3.0% | -2.4% | +3.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -23.1% | -126.1% | +7.1% | +167.7% | -11.3% |
Valuation Metrics
CBT leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 13.5x trailing earnings, CBT trades at a 29% valuation discount to RPM's 19.0x P/E. Adjusting for growth (PEG ratio), IOSP offers better value at 0.51x vs RPM's 1.05x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $4.2B | $811M | $1.3B | $1.9B | $13.0B |
| Enterprise ValueMkt cap + debt − cash | $5.2B | $1.4B | $4.7B | $1.7B | $15.6B |
| Trailing P/EPrice ÷ TTM EPS | 13.50x | -7.34x | -2.83x | 16.41x | 18.95x |
| Forward P/EPrice ÷ next-FY EPS est. | 13.04x | — | — | 15.45x | 18.48x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.51x | 1.05x |
| EV / EBITDAEnterprise value multiple | 6.71x | 40.71x | 16.80x | 8.29x | 14.22x |
| Price / SalesMarket cap ÷ Revenue | 1.14x | 0.44x | 0.46x | 1.07x | 1.76x |
| Price / BookPrice ÷ Book value/share | 2.58x | 1.08x | 0.92x | 1.44x | 4.50x |
| Price / FCFMarket cap ÷ FCF | 10.86x | — | — | 21.68x | 24.13x |
Profitability & Efficiency
Evenly matched — CBT and IOSP and RPM each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
RPM delivers a 21.3% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $-30 for TROX. IOSP carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to TROX's 2.48x. On the Piotroski fundamental quality scale (0–9), RPM scores 7/9 vs TROX's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +16.8% | -17.0% | -30.4% | +9.0% | +21.3% |
| ROA (TTM)Return on assets | +7.4% | -9.4% | -7.7% | +6.5% | +8.5% |
| ROICReturn on invested capital | +17.4% | -1.9% | -0.3% | +11.2% | +13.3% |
| ROCEReturn on capital employed | +21.3% | -2.2% | -0.4% | +11.0% | +15.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 2 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.71x | 0.77x | 2.48x | 0.07x | 1.03x |
| Net DebtTotal debt minus cash | $957M | $540M | $3.4B | -$203M | $2.7B |
| Cash & Equiv.Liquid assets | $258M | $37M | $211M | $293M | $302M |
| Total DebtShort + long-term debt | $1.2B | $577M | $3.6B | $90M | $3.0B |
| Interest CoverageEBIT ÷ Interest expense | 14.72x | -2.32x | -1.16x | — | 8.51x |
Total Returns (Dividends Reinvested)
RPM leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CBT five years ago would be worth $14,321 today (with dividends reinvested), compared to $4,493 for TROX. Over the past 12 months, TROX leads with a +76.9% total return vs IOSP's -14.9%. The 3-year compound annual growth rate (CAGR) favors RPM at 10.0% vs TROX's -8.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +21.9% | +58.5% | +98.1% | +0.5% | -1.2% |
| 1-Year ReturnPast 12 months | +13.8% | -1.2% | +76.9% | -14.9% | -5.3% |
| 3-Year ReturnCumulative with dividends | +22.5% | -0.7% | -23.6% | -17.3% | +33.3% |
| 5-Year ReturnCumulative with dividends | +43.2% | -43.9% | -55.1% | -18.3% | +13.4% |
| 10-Year ReturnCumulative with dividends | +115.7% | +129.0% | +116.1% | +84.4% | +134.7% |
| CAGR (3Y)Annualised 3-year return | +7.0% | -0.2% | -8.6% | -6.1% | +10.0% |
Risk & Volatility
Evenly matched — CBT and IOSP each lead in 1 of 2 comparable metrics.
Risk & Volatility
IOSP is the less volatile stock with a 0.70 beta — it tends to amplify market swings less than TROX's 2.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CBT currently trades 96.1% from its 52-week high vs RPM's 78.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.78x | 1.57x | 2.37x | 0.70x | 1.01x |
| 52-Week HighHighest price in past year | $84.60 | $7.90 | $10.59 | $95.55 | $129.12 |
| 52-Week LowLowest price in past year | $58.33 | $4.08 | $2.86 | $65.58 | $92.92 |
| % of 52W HighCurrent price vs 52-week peak | +96.1% | +89.2% | +79.4% | +80.2% | +78.5% |
| RSI (14)Momentum oscillator 0–100 | 71.7 | 63.4 | 58.5 | 59.1 | 47.7 |
| Avg Volume (50D)Average daily shares traded | 374K | 350K | 3.1M | 221K | 932K |
Analyst Outlook
Evenly matched — TROX and RPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CBT as "Buy", KRO as "Hold", TROX as "Buy", IOSP as "Hold", RPM as "Buy". Consensus price targets imply 50.1% upside for IOSP (target: $115) vs -29.1% for KRO (target: $5). For income investors, TROX offers the higher dividend yield at 3.60% vs RPM's 1.97%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $78.00 | $5.00 | $7.25 | $115.00 | $122.67 |
| # AnalystsCovering analysts | 15 | 7 | 17 | 9 | 22 |
| Dividend YieldAnnual dividend ÷ price | +2.2% | +2.8% | +3.6% | +2.2% | +2.0% |
| Dividend StreakConsecutive years of raises | 4 | 0 | 0 | 12 | 30 |
| Dividend / ShareAnnual DPS | $1.77 | $0.20 | $0.30 | $1.70 | $1.99 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.0% | 0.0% | 0.0% | 0.0% | +0.7% |
CBT leads in 1 of 6 categories (Valuation Metrics). RPM leads in 1 (Total Returns). 4 tied.
CBT vs KRO vs TROX vs IOSP vs RPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CBT or KRO or TROX or IOSP or RPM a better buy right now?
For growth investors, RPM International Inc.
(RPM) is the stronger pick with 0. 5% revenue growth year-over-year, versus -7. 0% for Cabot Corporation (CBT). Cabot Corporation (CBT) offers the better valuation at 13. 5x trailing P/E (13. 0x forward), making it the more compelling value choice. Analysts rate Cabot Corporation (CBT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CBT or KRO or TROX or IOSP or RPM?
On trailing P/E, Cabot Corporation (CBT) is the cheapest at 13.
5x versus RPM International Inc. at 19. 0x. On forward P/E, Cabot Corporation is actually cheaper at 13. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Innospec Inc. wins at 0. 48x versus RPM International Inc. 's 1. 03x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CBT or KRO or TROX or IOSP or RPM?
Over the past 5 years, Cabot Corporation (CBT) delivered a total return of +43.
2%, compared to -55. 1% for Tronox Holdings plc (TROX). Over 10 years, the gap is even starker: RPM returned +134. 7% versus IOSP's +84. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CBT or KRO or TROX or IOSP or RPM?
By beta (market sensitivity over 5 years), Innospec Inc.
(IOSP) is the lower-risk stock at 0. 70β versus Tronox Holdings plc's 2. 37β — meaning TROX is approximately 239% more volatile than IOSP relative to the S&P 500. On balance sheet safety, Innospec Inc. (IOSP) carries a lower debt/equity ratio of 7% versus 2% for Tronox Holdings plc — giving it more financial flexibility in a downturn.
05Which is growing faster — CBT or KRO or TROX or IOSP or RPM?
By revenue growth (latest reported year), RPM International Inc.
(RPM) is pulling ahead at 0. 5% versus -7. 0% for Cabot Corporation (CBT). On earnings-per-share growth, the picture is similar: Innospec Inc. grew EPS 228. 9% year-over-year, compared to -890. 0% for Tronox Holdings plc. Over a 3-year CAGR, RPM leads at 3. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CBT or KRO or TROX or IOSP or RPM?
RPM International Inc.
(RPM) is the more profitable company, earning 9. 3% net margin versus -16. 2% for Tronox Holdings plc — meaning it keeps 9. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CBT leads at 16. 7% versus -1. 7% for KRO. At the gross margin level — before operating expenses — RPM leads at 41. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CBT or KRO or TROX or IOSP or RPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Innospec Inc. (IOSP) is the more undervalued stock at a PEG of 0. 48x versus RPM International Inc. 's 1. 03x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Cabot Corporation (CBT) trades at 13. 0x forward P/E versus 18. 5x for RPM International Inc. — 5. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IOSP: 50. 1% to $115. 00.
08Which pays a better dividend — CBT or KRO or TROX or IOSP or RPM?
All stocks in this comparison pay dividends.
Tronox Holdings plc (TROX) offers the highest yield at 3. 6%, versus 2. 0% for RPM International Inc. (RPM).
09Is CBT or KRO or TROX or IOSP or RPM better for a retirement portfolio?
For long-horizon retirement investors, Innospec Inc.
(IOSP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 70), 2. 2% yield). Tronox Holdings plc (TROX) carries a higher beta of 2. 37 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IOSP: +84. 4%, TROX: +116. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CBT and KRO and TROX and IOSP and RPM?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CBT is a small-cap deep-value stock; KRO is a small-cap quality compounder stock; TROX is a small-cap income-oriented stock; IOSP is a small-cap deep-value stock; RPM is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.